common side effects
phase
complicated intraabdominal infection
ciai
trial
vomiting
nausea
serious side effects
patients
drug with metronidazole
patients
using meropenem
common side effects
discontinuation of this drug
skin
subcutaneous tissue disorders
phase ciai trial
death
patients
drug with metronidazole
patients
using meropenem
common side effects
phase
complicated urinary tract infection trial
constipation
anxiety
serious side effects
patients
drug
patients
using imipenem-cilastatin
drug
patient
accidental overdose
patient
atrial fibrillation
vomiting
nausea
constipation
abdominal pain
upper abdominal painfrequency
clostridium
difficile-associated diarrhea
phase ciai trial
death
patients
drug with metronidazole
patients
using meropenem
subgroup of patients with baseline crcl
ml/min
death
patients
drug with metronidazole
patients
using meropenem
patients
drug
lower daily dose
patient population
patients with baseline crcl
ml/min
death
patients
drug with metronidazole
patients
using meropenem
cause of death
contributing factors
progression
underlying infection
baseline pathogens
drug
delayed surgical intervention
seroconversion from negative
positive direct coombs test result
deathfrequency
decreased clinical response
accidental overdoseceftazidime
frequency
candidiasis
anxiety
increased blood alkaline phosphatasefrequency
hypokalemiaceftazidime
frequency
increased blood lactate dehydrogenase
increased blood altfrequency
increased ggtceftazidime
frequency
jaundice
dizzinessceftazidime
frequency
dysgeusia
paresthesia
seizures
nonconvulsive status epilepticus
encephalopathy
coma
asterixis
neuromuscular excitability
myoclonia
frequency
acute renal failure
renal impairmentceftazidime
frequency
tubulointerstitial nephritis
frequency
rash
skin
subcutaneous tissue disordersbeta-lactam
antibacterial drugs
frequency
serious skin reactionsceftazidime
frequency
angioedema
erythema multiforme
pruritus
stevens-johnson syndrome
toxic epidermal necrolysis
urticaria
frequency
eosinophilia
thrombocytopenia
prolonged prothrombin timeceftazidime
frequency
agranulocytosis
hemolytic anemia
leukopenia
lymphocytosis
neutropenia
thrombocytosis
frequency
atrial fibrillation
beta-lactam antibacterial drugs
frequency
fatal hypersensitivity
anaphylactic
reactions
ceftazidime
frequency
infusion-site inflammation
injection-site hematoma
injections-site phlebitis
injection-site thrombosis
ceftazidime
frequency
vaginal inflammation
agitation
black, tarry stools
bleeding gums
blood in the urine
stools
bluish color changes in skin color
chest pain
chills
coma
confusion
convulsions
cough
decreased urine
dizziness
fever
headache
hostility
increased thirst
irregular heartbeat
lethargy
loss of appetite
muscle pain
cramps
muscle twitching
nausea or vomiting
numbness
tingling in the hands
feet
lips
difficult urination
red spots on the skin
rapid weight gain
seizures
sore throat
sores
ulcers
white spots on the lips
mouth
stupor
swelling of the face
ankles
hands
foot
leg
swollen glands
tenderness
unusual bleeding
bruising
unusual tiredness
weakness
difficulty swallowing
fast heartbeat
hives
itching
skin rash
puffiness
swelling of the eyelids
eyes
face
lips
tongue
tightness in the chest
stomach pain
diarrhea
difficulty
bowel movement
stool
change in taste
loss of taste
redness of the skin
white patches in the mouth
throat
tongue
white patches with diaper rash